Stay updated with breaking news from Nasdaq Ctic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
JMP Securities lowered shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) from an outperform rating to a market perform rating in a research note issued to investors on Thursday, The Fly reports. Several other equities research analysts have also recently issued reports on the stock. StockNews.com raised shares of CTI BioPharma from a sell rating […]
A number of firms have modified their ratings and price targets on shares of CTI BioPharma (NASDAQ: CTIC) recently: 5/15/2023 – CTI BioPharma was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. 5/11/2023 – CTI BioPharma was downgraded by analysts at JMP Securities from an “outperform” rating to a […]
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) was the target of a large decrease in short interest in the month of April. As of April 30th, there was short interest totalling 12,170,000 shares, a decrease of 24.2% from the April 15th total of 16,050,000 shares. Based on an average trading volume of 3,010,000 shares, the […]
Needham & Company LLC lowered shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) from a buy rating to a hold rating in a report published on Wednesday, The Fly reports. Other analysts have also issued reports about the stock. TD Cowen reduced their price target on shares of CTI BioPharma from $10.00 to $8.00 and […]
Needham & Company LLC cut shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) from a buy rating to a hold rating in a research report sent to investors on Wednesday, The Fly reports. CTIC has been the subject of a number of other reports. StockNews.com raised CTI BioPharma from a sell rating to a hold […]